- Home
- ARVN vs WABC Comparison
ARVN vs WABC Comparison
Compare ARVN & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- WABC
- Stock Information
- Founded
- ARVN 2015
- WABC 1972
- Country
- ARVN United States
- WABC United States
- Employees
- ARVN N/A
- WABC N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- WABC Major Banks
- Sector
- ARVN Health Care
- WABC Finance
- Exchange
- ARVN Nasdaq
- WABC Nasdaq
- Market Cap
- ARVN 1.2B
- WABC 1.3B
- IPO Year
- ARVN 2018
- WABC N/A
- Fundamental
- Price
- ARVN $7.02
- WABC $50.63
- Analyst Decision
- ARVN Buy
- WABC Hold
- Analyst Count
- ARVN 13
- WABC 3
- Target Price
- ARVN $34.42
- WABC $57.00
- AVG Volume (30 Days)
- ARVN 3.5M
- WABC 181.6K
- Earning Date
- ARVN 05-06-2025
- WABC 04-17-2025
- Dividend Yield
- ARVN N/A
- WABC 3.47%
- EPS Growth
- ARVN N/A
- WABC N/A
- EPS
- ARVN N/A
- WABC 5.20
- Revenue
- ARVN $263,399,999.00
- WABC $293,248,000.00
- Revenue This Year
- ARVN N/A
- WABC N/A
- Revenue Next Year
- ARVN $7.99
- WABC N/A
- P/E Ratio
- ARVN N/A
- WABC $9.77
- Revenue Growth
- ARVN 235.54
- WABC N/A
- 52 Week Low
- ARVN $6.88
- WABC $45.11
- 52 Week High
- ARVN $41.34
- WABC $59.97
- Technical
- Relative Strength Index (RSI)
- ARVN 23.50
- WABC 47.89
- Support Level
- ARVN $8.51
- WABC $50.59
- Resistance Level
- ARVN $9.17
- WABC $52.34
- Average True Range (ATR)
- ARVN 0.55
- WABC 1.03
- MACD
- ARVN -0.05
- WABC -0.03
- Stochastic Oscillator
- ARVN 5.24
- WABC 43.00
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California, and all the way east to Nevada County.